Literature DB >> 14563295

[Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes].

Antonia Sambola1, Valentín Fuster, Juan José Badimon.   

Abstract

Recent advances in basic science have linked some systemic risk factors to endothelial dysfunction which gives rise to atherosclerotic disease and triggers the progression of thrombotic complications. Superficial erosion of the stenotic plaque can be observed in one-third of acute coronary syndromes (ACS). In these cases the presence of classic risk factors such as diabetes mellitus, hypercholesterolemia and smoking favor a state of "vulnerable blood" or high risk. Increased thrombogenicity can exacerbate thrombus formation and is able to trigger an ACS. The vessel endothelium regulates contractile, mitogenic and thrombotic activities of the vessel wall. Risk factors impair both homeostasis and hemostasis of the vessel wall and promote inflammatory signals. Platelet and monocyte activation favors the expression of tissue factor (TF), thus triggering the coagulation cascade with thrombin generation and clot formation. Increased blood thrombogenicity linked to classic risk factors may be associated with circulating TF levels which are much higher than those observed in healthy subjects without risk factors. These observations not only emphasize the usefulness of aggressive management of risk factors but open a new avenue for future studies to devise therapeutic strategies to treat ACS by inhibiting TF expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563295     DOI: 10.1016/s0300-8932(03)76998-x

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  4 in total

1.  [Cardiovascular risk in Spanish smokers compared to non-smokers: RETRATOS study].

Authors:  Jaime Fernández de Bobadilla; Verónica Sanz de Burgoa; Patricio Garrido Morales; Esteban López de Sá
Journal:  Aten Primaria       Date:  2011-03-21       Impact factor: 1.137

Review 2.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

3.  Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.

Authors:  Trine B Opstad; Alf Age Pettersen; Thomas Weiss; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2010-05-05

4.  Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.

Authors:  Yu Mi Ha; Eun Jung Park; Young Jin Kang; Sang Won Park; Hye Jung Kim; Ki Churl Chang
Journal:  J Cell Mol Med       Date:  2014-08-11       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.